Session Time: 3:15pm-4:00pm
Presentation Time: 3:30pm-4:00pm
*Purpose: Kidney transplantation from a living donor is the best treatment option for End Stage Kidney Disease. Considering the shortage of available organs, transplant centers are increasingly evaluating marginal kidney donors. The acceptance of donors with family history of kidney disease can be very challenging . To form consensus a survey was sent to nephrologists and transplant surgeons about suitability and acceptance of marginal live kidney donors with a family history of kidney disease.
*Methods: A cross-sectional survey was mainly distributed through AST and ERA-EDTA. In-training providers were excluded
*Results: A total of (N=122) respondents from 22 countries answered two questions about donors with family history of kidney disease . Of those, 96 (80.2%) were nephrologists and 23 (19.83%) were transplant surgeons. The majority were heavily involved in pre-transplant evaluations of donors and recipients and have > 6 years in practice.The majority ( N=63, 52 % ) of respondents would not accept a young donor with strong family history of kidney disease of unknown etiology despite negative evaluation.The approval rate did not change even in the case there were no alternative donor and the donor insisted to donate (N=25, 20% versus N=23, 23% ; P= NS).
*Conclusions: Family history of kidney disease of unknown etiology is an important factor to decline young donors even if there were no alternative donor.
To cite this abstract in AMA style:Arabi Z, Kaysi S, Altheaby A, Elhassan E, Bukhari M, Mateen A, Hamad A. Multi- National Survey among Nephrologists and Transplant Surgeons about the Suitability and Acceptance of the Marginal Live Kidney Donors with Family History of Kidney Disease [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/multi-national-survey-among-nephrologists-and-transplant-surgeons-about-the-suitability-and-acceptance-of-the-marginal-live-kidney-donors-with-family-history-of-kidney-disease/. Accessed November 24, 2020.
« Back to 2020 American Transplant Congress